APA (7th ed.) Citation

Diamant, M., Van Gaal, L., Stranks, S., Northrup, J., Cao, D., Taylor, K., & Trautmann, M. (2010). Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): An open-label randomised trial. Lancet, 375(9733), 2234. https://doi.org/10.1016/S0140-6736(10)60406-0

Chicago Style (17th ed.) Citation

Diamant, Michaela, Luc Van Gaal, Stephen Stranks, Justin Northrup, Dachuang Cao, Kristin Taylor, and Michael Trautmann. "Once Weekly Exenatide Compared with Insulin Glargine Titrated to Target in Patients with Type 2 Diabetes (DURATION-3): An Open-label Randomised Trial." Lancet 375, no. 9733 (2010): 2234. https://doi.org/10.1016/S0140-6736(10)60406-0.

MLA (9th ed.) Citation

Diamant, Michaela, et al. "Once Weekly Exenatide Compared with Insulin Glargine Titrated to Target in Patients with Type 2 Diabetes (DURATION-3): An Open-label Randomised Trial." Lancet, vol. 375, no. 9733, 2010, p. 2234, https://doi.org/10.1016/S0140-6736(10)60406-0.